HRGN

Harvard Apparatus Regenerative Technology, Inc.

OTCHealthcareSurgical & Medical Instruments & Apparatus

Insider activity for last month from 08/25 to 09/25. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Latest filingSep 25, 2026Most recent Form 4
Total buying$394k2 buys
Total selling$00 sells
Net open-market+$394k1 insiders
Open-market mix
Buy vs sell distribution by transaction count
2 transactions
2 buys100%·0%0 sells

Insider activity report

Monthly purchases, sales and code-A awards
Buys Sells Awards / grants (A)
530-3-5transactionsAugSep 2026 buys: 2 transactions · $394k2Sep

Code A includes awards, grants and other acquisitions; these are not open-market buys.

Distinct insiders active

Reporting-owner CIKs by month · peak Sep 2026 (1)
Aug 2026Sep 2026
1distinct insiders in 2 months
Top insiders
By absolute net value across the selected period
1 insiders
  • HJ
    He JunliCEO · rank 1 · 2 buys · 0 sells · 0 awards (A)
    +$1.1Mlast 09/25/2026
Recent filing activity
Most recent 6 transactions · color = transaction code
  • CUnknown09/25
    HRGN · Harvard Apparatus Regenerative Technology, Inc. · He Junli · CEO
    —trade 09/11SEC
  • CUnknown09/25
    HRGN · Harvard Apparatus Regenerative Technology, Inc. · He Junli · CEO
    —trade 09/11SEC
  • CUnknown09/25
    HRGN · Harvard Apparatus Regenerative Technology, Inc. · He Junli · CEO
    —trade 09/11SEC
  • PBuy09/25
    HRGN · Harvard Apparatus Regenerative Technology, Inc. · He Junli · CEO
    $14.4ktrade 09/15SEC
  • PBuy09/25
    HRGN · Harvard Apparatus Regenerative Technology, Inc. · He Junli · CEO
    $380ktrade 09/11SEC
  • CUnknown09/25
    HRGN · Harvard Apparatus Regenerative Technology, Inc. · He Junli · CEO
    $717ktrade 09/11SEC

Filing detail checks

Secondary metrics for the selected period
Largest buy$380k
Largest sale-
10b5-1 detected0
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
6transactionstxns
  • C · Code C · dominant4 · 67%
  • P · Open-market buys2 · 33%

Activity by reported role

A joint filing can contribute to multiple roles
6transactionstxns
  • Chief executive officer · dominant6 · 100%

Reported Holdings After

Separated by insider, security, and ownership type

He JunliCommon Stock · Direct
1.3M964.3kSep 11, 2026Sep 15, 2026
1,332,930Sep 15, 2026
He JunliBridge Note (07/16/2026) · Direct
00Sep 11, 2026Sep 11, 2026
0Sep 11, 2026
He JunliBridge Note (05/13/2026) · Direct
00Sep 11, 2026Sep 11, 2026
0Sep 11, 2026
He JunliBridge Note (04/14/2026) · Direct
00Sep 11, 2026Sep 11, 2026
0Sep 11, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells red
1 active days
Aug 25 → Sep 25
LessMore

Filing-only signals

Deterministic matches in the selected period

No filing-only signal badges matched this period.

HRGN transaction history

Filters apply within this company and selected period by default
Reset

Latest insider transactions

Form 4 filings from last month. Click any column to sort; click it again to flip the order.

Newest company filings
IDTickerInsiderRoleTypeSharesValueCodeFiledTrans date
#229600HRGNHe Junli
CEO
unknown202k—C09/2509/11
#229599HRGNHe Junli
CEO
unknown205k—C09/2509/11
#229598HRGNHe Junli
CEO
unknown310k—C09/2509/11
#229597HRGNHe Junli
CEO
buy6.72k$1.44MP09/2509/15
#229596HRGNHe Junli
CEO
buy361k$38.0MP09/2509/11
#229595HRGNHe Junli
CEO
unknown683k$71.7MC09/2509/11

Harvard Apparatus Regenerative Technology, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Harvard Apparatus Regenerative Technology, Inc.?

He Junli.

When was the latest reported open-market purchase?

He Junli reported a buy on Sep 15, 2026 valued at $14.4k. Read the SEC filing.

When was the latest reported open-market sale?

No code-S sale is available for this period.

What is the recent purchase and sale balance?

Net open-market buying in the selected period was $394,459.00. This describes filed transactions, not a bullish rating.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.